380 related articles for article (PubMed ID: 19285275)
21. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.
Goldshmidt O; Zcharia E; Abramovitch R; Metzger S; Aingorn H; Friedmann Y; Schirrmacher V; Mitrani E; Vlodavsky I
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10031-6. PubMed ID: 12097647
[TBL] [Abstract][Full Text] [Related]
22. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
23. Structure and biology of tissue factor pathway inhibitor.
Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
[TBL] [Abstract][Full Text] [Related]
24. Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells.
Martinez-Sales V; Vila V; Réganon E; Oms JG; Aznar J
Haematologica; 2003 Jun; 88(6):694-9. PubMed ID: 12801846
[TBL] [Abstract][Full Text] [Related]
25. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.
Escobar Galvis ML; Jia J; Zhang X; Jastrebova N; Spillmann D; Gottfridsson E; van Kuppevelt TH; Zcharia E; Vlodavsky I; Lindahl U; Li JP
Nat Chem Biol; 2007 Dec; 3(12):773-8. PubMed ID: 17952066
[TBL] [Abstract][Full Text] [Related]
26. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
27. Heparanase-A Link between Coagulation, Angiogenesis, and Cancer.
Nadir Y; Brenner B
Rambam Maimonides Med J; 2012 Jan; 3(1):e0002. PubMed ID: 23908827
[TBL] [Abstract][Full Text] [Related]
28. Involvement of Heparanase in early pregnancy losses.
Nadir Y; Henig I; Naroditzky I; Paz B; Vlodavsky I; Brenner B
Thromb Res; 2010 May; 125(5):e251-7. PubMed ID: 20031192
[TBL] [Abstract][Full Text] [Related]
29. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass.
Kram V; Zcharia E; Yacoby-Zeevi O; Metzger S; Chajek-Shaul T; Gabet Y; Müller R; Vlodavsky I; Bab I
J Cell Physiol; 2006 Jun; 207(3):784-92. PubMed ID: 16514606
[TBL] [Abstract][Full Text] [Related]
30. Histidine-rich glycoprotein binds heparanase and regulates its enzymatic activity and cell surface interactions.
Poon IK; Yee DY; Jones AL; Wood RJ; Davis DS; Freeman C; Parish CR; Hulett MD
Int J Biochem Cell Biol; 2010 Sep; 42(9):1507-16. PubMed ID: 20561914
[TBL] [Abstract][Full Text] [Related]
31. Heparanase regulates esophageal keratinocyte differentiation through nuclear translocation and heparan sulfate cleavage.
Kobayashi M; Naomoto Y; Nobuhisa T; Okawa T; Takaoka M; Shirakawa Y; Yamatsuji T; Matsuoka J; Mizushima T; Matsuura H; Nakajima M; Nakagawa H; Rustgi A; Tanaka N
Differentiation; 2006 Jun; 74(5):235-43. PubMed ID: 16759289
[TBL] [Abstract][Full Text] [Related]
32. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.
Ruf W; Seftor EA; Petrovan RJ; Weiss RM; Gruman LM; Margaryan NV; Seftor RE; Miyagi Y; Hendrix MJ
Cancer Res; 2003 Sep; 63(17):5381-9. PubMed ID: 14500372
[TBL] [Abstract][Full Text] [Related]
33. Heparanase role in the treatment of avascular necrosis of femur head.
Peled E; Davis M; Axelman E; Norman D; Nadir Y
Thromb Res; 2013 Jan; 131(1):94-8. PubMed ID: 23063054
[TBL] [Abstract][Full Text] [Related]
34. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M
Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
[TBL] [Abstract][Full Text] [Related]
35. Heparanase: one molecule with multiple functions in cancer progression.
Vlodavsky I; Elkin M; Abboud-Jarrous G; Levi-Adam F; Fuks L; Shafat I; Ilan N
Connect Tissue Res; 2008; 49(3):207-10. PubMed ID: 18661344
[TBL] [Abstract][Full Text] [Related]
36. Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons.
Lupu C; Kruithof EK; Kakkar VV; Lupu F
Thromb Haemost; 1999 Dec; 82(6):1652-8. PubMed ID: 10613651
[TBL] [Abstract][Full Text] [Related]
37. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.
Hackeng TM; Seré KM; Tans G; Rosing J
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3106-11. PubMed ID: 16488980
[TBL] [Abstract][Full Text] [Related]
38. Heparanase affects adhesive and tumorigenic potential of human glioma cells.
Zetser A; Bashenko Y; Miao HQ; Vlodavsky I; Ilan N
Cancer Res; 2003 Nov; 63(22):7733-41. PubMed ID: 14633698
[TBL] [Abstract][Full Text] [Related]
39. Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models.
Zcharia E; Zilka R; Yaar A; Yacoby-Zeevi O; Zetser A; Metzger S; Sarid R; Naggi A; Casu B; Ilan N; Vlodavsky I; Abramovitch R
FASEB J; 2005 Feb; 19(2):211-21. PubMed ID: 15677344
[TBL] [Abstract][Full Text] [Related]
40. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
